Stroke Unit, University Hospital, Nancy, France.
Clinical Investigation Centre 1433, INSERM, University Hospital, Université de Lorraine, Nancy, France.
Eur J Neurol. 2021 Jan;28(1):141-151. doi: 10.1111/ene.14509. Epub 2020 Oct 13.
Intravenous thrombolysis plus mechanical thrombectomy (IVT + MT) is the best current management of acute stroke due to large-vessel occlusion and results in optimal reperfusion for most patients. Nevertheless, some of these patients do not subsequently achieve functional independence. The aim was to identify baseline factors associated with 3-month independence after optimal reperfusion and to validate a prediction model.
All consecutive patients with intracranial anterior large-vessel occlusion, with indication for IVT + MT and achieving optimal reperfusion (defined as modified Treatment in Cerebral Ischaemia score 2b-3), from the THRACE trial and the ETIS registry, were included in order to identify a prediction model. The primary outcome was 3-month independence [modified Rankin Scale (mRS) score ≤ 2]. Multivariate inferences invoked forward logistic regression, multiple imputation and bootstrap resampling. Predictive performance was assessed by c-statistic. Model validation was conducted on patients from the ASTER trial.
Amongst 139 patients (mean age 65.5 years; 54.3% female), predictors of 3-month mRS ≤ 2 (n = 82) were younger age [odds ratio 0.62 per 10-year increase; 95% confidence interval (CI) 0.53-0.72] and higher Alberta Stroke Program Early Computed Tomography Score (ASPECTS) (odds ratio 1.65 per 1-point increase; 95% CI 1.47-1.86) with c-statistic 0.77. Model validation (n = 104/181 patients with 3-month mRS ≤ 2) demonstrated a moderate discrimination (c-statistic 0.74; 95% CI 0.66-0.81) combining age and ASPECTS. The validation model was improved by the adjunction of three candidate variables that were found to be predictors. Addition of baseline National Institutes of Health Stroke Scale (NIHSS) score, history of vascular risk factor and onset-to-reperfusion time significantly improved discrimination (c-statistic 0.85; 95% CI 0.83-0.87).
After optimal reperfusion, younger age, higher ASPECTS, lower NIHSS score, shorter onset-to-reperfusion time and absence of vascular risk factor were predictive of independence and could help to guide patient management.
静脉溶栓联合机械取栓(IVT+MT)是目前治疗大血管闭塞性急性卒中的最佳方法,可使大多数患者实现最佳再灌注。然而,这些患者中的一些并不能随后实现功能独立。本研究旨在确定与最佳再灌注后 3 个月独立性相关的基线因素,并验证一个预测模型。
我们纳入了 THRACE 试验和 ETIS 登记研究中所有连续的颅内前循环大血管闭塞患者,这些患者适合接受 IVT+MT 治疗,并达到了最佳再灌注(定义为改良治疗急性缺血性卒中试验评分 2b-3),以确定一个预测模型。主要结局为 3 个月时的独立性[改良 Rankin 量表(mRS)评分≤2]。多变量推断采用向前逻辑回归、多重插补和自举重采样。通过 C 统计量评估预测性能。模型验证在 ASTER 试验的患者中进行。
在 139 例患者(平均年龄 65.5 岁,54.3%为女性)中,3 个月时 mRS≤2(n=82)的预测因素为年龄较小[每增加 10 岁,优势比为 0.62;95%置信区间(CI)为 0.53-0.72]和 Alberta 卒中项目早期 CT 评分(ASPECTS)较高[每增加 1 分,优势比为 1.65;95%CI 为 1.47-1.86],C 统计量为 0.77。模型验证(n=181 例患者中的 104 例,3 个月时 mRS≤2)显示,年龄和 ASPECTS 联合的中等判别能力(C 统计量为 0.74;95%CI 为 0.66-0.81)。将三个候选变量(基线 NIHSS 评分、血管危险因素史和起病至再灌注时间)添加到模型中,发现这些变量可作为预测因素,从而改善了验证模型。添加 NIHSS 评分、血管危险因素史和起病至再灌注时间可显著提高判别能力(C 统计量为 0.85;95%CI 为 0.83-0.87)。
在达到最佳再灌注后,年龄较小、ASPECTS 较高、NIHSS 评分较低、起病至再灌注时间较短以及无血管危险因素与独立性相关,有助于指导患者管理。